Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Friday, December 31, 2021 4:43:23 PM
Isn't it interesting several pharmaceutical companies have a history of forming partnerships with The Weill Cornell University Medical College that aims to speed the drug discovery process of new clinical treatments. Not only this, they're supported by The Bill & Melinda Gates Foundation at the tune of at least $20M.
PROOF:
https://news.weill.cornell.edu/news/2012/06/weill-cornell-partners-with-pharmaceutical-companies-and-academic-researchers-to-speed-tuberculosis
This is what the Canary Acquisition is based on, i.e. to license their technology in the scope of the drug discovery process that's going to required $50M funding.
If this acquisition goes through, it will instantly result in a fundamental change in RGBP's Market Profile and put them on the Fast Track for advancing toward market for new clinical therapeutics based in their I.P. Portfolio which is the EXACT reason Dr. Koos made it his business this year to aggressively ACTIVATE several of his expired Patents.
IS THIS MAKING SENSE YET??? IF NOT, IT SHOULD!
Let's just hope that Acquisition goes through.
Be well and prosper...
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM